JMJ. G. Mahdi

J. G. Mahdi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. G. Mahdi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • A. J. Mahdi

    Medical School, Stopford Building, University of Manchester, Oxford Road, Manchester, M13 9PT, UK

    2 shared publications
  • I. D. Bowen

    School of Biosciences, Cardiff University, PO Box 911, Cardiff CF10 3US, UK

    2 shared publications
  • D. Humam

    School of Biosciences, Cardiff University, PO Box 911, Cardiff CF10 3US, UK

    1 shared publication
  • M. A. Alkarrawi

    School of Biosciences, Cardiff University, PO Box 911, Cardiff CF10 3US, UK

    1 shared publication

Latest Publications

  • Calcium salicylate‐mediated apoptosis in human HT‐1080 fibrosarcoma cells

    by J. G. Mahdi, M. A. Alkarrawi, A. J. Mahdi, I. D. Bowen, D. Humam

    Salicylates are novel biologically active compounds that exhibit multiple therapeutic activities. The anti-cancer effectiveness of calcium salicylate has been investigated on human HT-1080 fibrosarcoma cell lines at relatively low concentrations (predominantly 0.4 mM) compared to those previously reported. Although low calcium salicylate concentrations did not retard tumour growth progression significantly, as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and time-lapse assays, its cytotoxic characteristics were proven to be prominent by various morphological and immunocytological techniques. The results here demonstrate evidence for approximately 25% apoptosis after treatment with calcium salicylate, which up-regulatd the expression of p53, p21 and Bax, and down-regulated Bcl-2 in HT-1080 cells.


  • Top Cited Papers

    The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential

    by J. G. Mahdi, A. J. Mahdi, I. D. Bowen

    Abstract.  For several millennia, the willow tree and salicin have been associated with salicylic acid, the key precursor molecule that has contributed to the discovery of acetylsalicylic acid, traded as aspirin. These molecules have been shown to possess phyto‐ and chemotherapeutic activities as analgesic drugs. In recent decades, aspirin has become the focus of extensive investigation into antiproliferative and anticancer activities. The historical steps that led to the discovery of aspirin, and its antiproliferative and anticancer potential are highlighted in this review.